Immune biomarker-based enrichment in sepsis trials
Crit Care
.
2020 Feb 19;24(1):58.
doi: 10.1186/s13054-020-2774-1.
Authors
Thibaud Spinetti
1
,
Christian Meisel
2
,
Stephan von Gunten
3
,
Joerg C Schefold
4
Affiliations
1
Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. thibaud.spinetti@insel.ch.
2
Department of Medical Immunology, Charité University Medicine Berlin, Berlin, Germany.
3
Institute of Pharmacology, University of Bern, Bern, Switzerland.
4
Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
PMID:
32075672
PMCID:
PMC7029545
DOI:
10.1186/s13054-020-2774-1
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers
Humans
Interleukin-8*
Prognosis
Prospective Studies
Sepsis*
Substances
Biomarkers
Interleukin-8